Funding opportunities
2,862 live opportunities from Grants.gov, NIH, NSF, and more.
AI & Machine LearningAgriculture & Food ScienceBiomedical & HealthBiology & Life SciencesChemistry & MaterialsClimate & EnvironmentCybersecurity & ITDefense & SecurityEconomics & BusinessEducation & WorkforceEnergy & SustainabilityEngineeringHumanities & ArtsInfrastructure & TransportationMathematics & StatisticsPhysics & AstronomyPublic HealthSmall Business (SBIR/STTR)Social Sciences & PolicySpace & AerospaceVeterinary & Animal ScienceWater & Oceans
- Evaluating the impact of nicotine pouch characteristics in the context of a combustible cigarette standard on overall tobacco product useNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $621,549activenih
- Mechanistic roles of bitter taste receptors in the pathogenesis and treatment of chronic rhinosinusitisNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $843,568activenih
- Malaria Reservoir Study (MRS) II: reducing parasite diversity to break intervention resilience in Plasmodium falciparum populations at high endemicityJohn E. Fogarty International Center for Advanced Study in the Health SciencesPAR-25-002 closes 5/31/2031up to $126,204activenih
- Malaria Reservoir Study (MRS) II: reducing parasite diversity to break intervention resilience in Plasmodium falciparum populations at high endemicityJohn E. Fogarty International Center for Advanced Study in the Health SciencesPAR-25-002 closes 5/31/2031up to $161,973activenih
- GlycoRNA control of immune homeostasisNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $825,050activenih
- Targeting Ribosome Biogenesis as a Non-Genotoxic Chemotherapy Strategy: Mechanistic Characterization of NVL Inhibition by BenzothiazepinonesNational Cancer InstitutePA-25-301 closes 5/31/2031up to $639,514activenih
- A novel "cap-linker" strategy to target oncolytic viruses to the tumorNational Cancer InstitutePA-25-301 closes 5/31/2031up to $499,568activenih
- Unleashing IFN signal transduction to prime HNSCC immunogenicityNational Cancer InstitutePA-25-301 closes 5/31/2031up to $742,382activenih
- Bioengineering of covalent proteins for nuclear medicine applicationsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $640,466activenih
- Uncovering the formation and function of fusion oncoprotein condensates in translocation renal cell carcinomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $643,861activenih
- Initiative for Maximizing Student Development (IMSD) (T32) at Rutgers University-NewarkNational Institute of General Medical SciencesPAR-24-031 closes 5/31/2031up to $581,440activenih
- Mechanisms of cannabidiol and sleep in the context of alcohol useNational Institute on Alcohol Abuse and AlcoholismPA-24-184 closes 5/31/2031up to $158,614activenih
- Multi-region neural dynamics of internally driven timing decisions, at spiking resolutionNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $564,007activenih
- The MYC Transcription Factor Network: Elucidating Oncogenic and Tumor Suppressive PathwaysNational Cancer InstitutePA-25-301 closes 5/31/2031up to $692,368activenih
- Interactive Functional Dynamics of Human K-Ras, Its Oncogenic Mutants and their Binding PartnersNational Cancer InstitutePA-25-301 closes 5/31/2031up to $463,692activenih
- Topical Therapy for Cutaneous Precancerous Lesions: a Digitally-enabled Randomized Controlled Trial of Fluorouracil compared with Fluorouracil/CalcipotrieneNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $704,028activenih
- Concomitant Inhibition of VAV3 and ERa to Treat High-Risk B-ALLNational Cancer InstitutePA-25-301 closes 5/31/2031up to $683,698activenih
- Neuroplastic mechanisms of dysphagia following stroke: Effects of aging and tongue exercise treatmentEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-301 closes 5/31/2031up to $614,993activenih
- Evaluating the Impact of a Novel Educational Intervention to Improve Timely Colposcopy Follow-Up and Treatment Among High-Risk PopulationsNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $702,461activenih
- Decoding the stromal niches of antigen-presenting cancer-associated fibroblast in pancreatic ductal adenocarcinomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $501,803activenih
- Ascertaining Multilevel drivers of hEad and Neck cancer Disparities (AMEND)National Institute of Dental and Craniofacial ResearchPAR-25-095 closes 5/31/2031up to $516,769activenih
- Biomarker Levels and Illnesses Associated with Exposure to Noncombustible and Combustible Tobacco Products in Young ChildrenNational Cancer InstitutePA-25-301 closes 5/31/2031up to $694,182activenih
- Bioinformatics guided synthesis of novel antibiotics from previously inaccessible microbial dark matterNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $798,670activenih
- Investigating the chromatin remodeling complex PBAF in small cell lung cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $577,750activenih
- Defining the gastrointestinal immune and microbiome response to shigella infection in childrenNational Institute of Allergy and Infectious DiseasesPA-24-176 closes 5/31/2031up to $159,764activenih